Mark D. Wittman

3.6k citations

57 papers · 1.2k · h-index 19

Impact in

Organic Chemistry top 5%
- Carbohydrate Chemistry and Synthesis
- Synthetic Organic Chemistry Methods
Endocrinology, Diabetes and Metabolism top 5%
- Growth Hormone and Insulin-like Growth Factors

Papers in

Nuclear and High Energy Physics 18
- Laser-Plasma Interactions and Diagnostics 17
Organic Chemistry 16
- Synthetic Organic Chemistry Methods 9

Co-authors: Dolatrai M. Vyas (20 shared papers)Samuel J. Danishefsky (4 shared papers)Randall L. Halcomb (4 shared papers)James Kallmerten (5 shared papers)Joan M. Carboni (9 shared papers)Marco M. Gottardis (8 shared papers)Ricardo M. Attar (7 shared papers)Ann Greer (8 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (11 papers)Fusion Science & Technology (8 papers)Tetrahedron Letters (7 papers)The Journal of Organic Chemistry (5 papers)Journal of Vacuum Science & Technology A Vacuum Surfaces and Films (5 papers)
Partner nations: United States Germany South Korea

In The Last Decade

Mark D. Wittman

54 papers receiving 1.2k citations

Peers

Countries citing papers authored by Mark D. Wittman

Since Specialization

Citations

This map shows the geographic impact of Mark D. Wittman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Wittman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Wittman more than expected).

Fields of papers citing papers by Mark D. Wittman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Wittman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Wittman. The network helps show where Mark D. Wittman may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark D. Wittman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark D. Wittman Line = papers co-authored together Mark D. Wittman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR Molecular Cancer Therapeutics ·Joan M. Carboni, Mark D. Wittman, Zheng Yang, Francis Lee, Ann Greer, Warren Hurlburt, Stephen Hillerman, Carolyn Cao, Glenn H. Cantor, Janet Dell-John, Cliff Chen, Lorell Discenza, Krista Menard, Aixin Li, George L. Trainor, Dolatrai M. Vyas, Robert A. Kramer, Ricardo M. Attar, Marco M. Gottardis	2009	218
2	In vitro and In vivo Antitumor Effects of the Dual Insulin-Like Growth Factor-I/Insulin Receptor Inhibitor, BMS-554417 Cancer Research ·Paul Haluska, Joan M. Carboni, David A. Loegering, Francis Y. Lee, Mark D. Wittman, Mark G. Saulnier, David B. Frennesson, Kimberly R. Kalli, Cheryl A. Conover, Ricardo M. Attar, Scott H. Kaufmann, Marco M. Gottardis, Charles Erlichman	2006	146
3	The synthesis of the core trisaccharide of esperamicin: corroboration of the proposed structure for its rearrangement product and stabilization of the core trisaccharide domain Journal of the American Chemical Society ·Randall L. Halcomb, Mark D. Wittman, Steven H. Olson, Samuel J. Danishefsky, Jerzy Golik, Henry Ν. C. Wong, Dolatrai M. Vyas	1991	65
4	On the conversion of biologically interesting amines to hydroxylamines The Journal of Organic Chemistry ·Mark D. Wittman, Randall L. Halcomb, Samuel J. Danishefsky	1990	62
5	Stereocontrolled synthesis of highly oxygenated acyclic systems via the enolate Claisen rearrangement of O-protected allylic glycolates The Journal of Organic Chemistry ·Thomas J. Gould, Michael Balestra, Mark D. Wittman, Jill A. Gary, Lucius T. Rossano, James Kallmerten	1987	54
6	A route to glycals in the allal and gulal series: synthesis of the thiosugar of esperamicin A1 The Journal of Organic Chemistry ·Mark D. Wittman, Randall L. Halcomb, Samuel J. Danishefsky, Jerzy Golik, Dolatrai M. Vyas	1990	49
7	Studies Related to the Carbohydrate Sectors of Esperamicin and Calicheamicin: Definition of the Stability Limits of the Esperamicin Domain and Fashioning of a Glycosyl Donor from the Calicheamicin Domain Journal of the American Chemical Society ·Randall L. Halcomb, Serge H. Boyer, Mark D. Wittman, Steven H. Olson, Derek J. Denhart, Kevin K.‐C. Liu, Samuel J. Danishefsky	1995	49
8	Synthesis and Antitumor Activity of Novel C-7 Paclitaxel Ethers: Discovery of BMS-184476 Journal of Medicinal Chemistry ·Thomas J. Altstadt, Craig R. Fairchild, Jerzy Golik, Kathy Johnston, John F. Kadow, Francis Y. Lee, Byron H. Long, William C. Rose, Dolatrai M. Vyas, Henry Ν. C. Wong, Mu-Jen Wu, Mark D. Wittman	2001	41
9	Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1 ACS Medicinal Chemistry Letters ·Andrew P. Degnan, Godwin Kumi, Christopher W. Allard, Erika Araujo, Walter L. Johnson, Kurt Zimmermann, Bradley C. Pearce, S. Sheriff, Alan Futran, Xin Li, Gregory Locke, Dan You, J. S. Morrison, Karen E. Parrish, Caitlyn Stromko, Anwar Murtaza, Jinqi Liu, Benjamin M. Johnson, Gregory D. Vite, Mark D. Wittman	2021	39
10	Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R) Bioorganic & Medicinal Chemistry Letters ·Upender Velaparthi, Mark D. Wittman, Peiying Liu, Karen M. Stoffan, Kurt Zimmermann, Xiaopeng Sang, Joan M. Carboni, Aixin Li, Ricardo M. Attar, Marco M. Gottardis, Ann Greer, ChiehYing Y. Chang, Bruce L. Jacobsen, John S. Sack, Yax Sun, David R. Langley, Balu Balasubramanian, Dolatrai M. Vyas	2007	36
11	Imidazole moiety replacements in the 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile Bioorganic & Medicinal Chemistry Letters ·Upender Velaparthi, Peiying Liu, Balu Balasubramanian, Joan M. Carboni, Ricardo M. Attar, Marco M. Gottardis, Aixin Li, Ann Greer, Mary Zoeckler, Mark D. Wittman, Dolatrai M. Vyas	2007	34
12	Synthesis and Antiviral Evaluation of 3′-Branched Nucixoside Analogues Nucleosides and Nucleotides ·Roman Sterzycki, John C. Martin, Mark D. Wittman, V. Rrankovan, Hao Yang, Michael J. M. Hitchcock, M. M. MANSURI	1991	27
13	The [2,3] Wittig rearrangement of tertiary allylic ethers. Application to the synthesis of the C12C25 subunit of zincophorin Tetrahedron Letters ·Michael Balestra, Mark D. Wittman, James Kallmerten	1988	24
14	Microwave-assisted synthesis of primary amine HX salts from halides and 7 M ammonia in methanol Tetrahedron Letters ·Mark G. Saulnier, Kurt Zimmermann, Charles Struzynski, Xiaopeng Sang, Upender Velaparthi, Mark D. Wittman, David B. Frennesson	2003	22
15	Diastereoselective [2,3] Wittig rearrangement of tertiary allylic ethers The Journal of Organic Chemistry ·Mark D. Wittman, James Kallmerten	1988	22
16	SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia Science Advances ·Céline Moison, Deanne Gracias, Julie Schmitt, Simon Girard, Jean-François Spinella, Simon Fortier, Isabel Boivin, Rodrigo Mendoza‐Sanchez, Bounkham Thavonekham, Tara MacRae, Nadine Mayotte, Éric Bonneil, Mark D. Wittman, James Carmichael, Réjean Ruel, Pierre Thibault, Josée Hébert, Anne Marinier, Guy Sauvageau	2024	21
17	2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924 Bioorganic & Medicinal Chemistry Letters ·Mark G. Saulnier, David B. Frennesson, Mark D. Wittman, Kurt Zimmermann, Upender Velaparthi, David R. Langley, Charles Struzynski, Xiaopeng Sang, Joan M. Carboni, Aixin Li, Ann Greer, Zheng Yang, Praveen Balimane, Marco M. Gottardis, Ricardo M. Attar, Dolatrai M. Vyas	2008	20
18	Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase Bioorganic & Medicinal Chemistry Letters ·Mark D. Wittman, Balu Balasubramanian, Karen M. Stoffan, Upender Velaparthi, Pieying Liu, Subramaniam Krishnanathan, Joan M. Carboni, Aixin Li, Ann Greer, Ricardo M. Attar, Marco M. Gottardis, ChiehYing Y. Chang, Bruce L. Jacobson, Yax Sun, Steven Hansel, Mary Zoeckler, Dolatrai M. Vyas	2006	19
19	Forming cryogenic targets for direct-drive experiments Physics of Plasmas ·D. R. Harding, D. D. Meyerhofer, S. J. Loucks, L. D. Lund, Roger Janezic, L. M. Elasky, T. H. Hinterman, D. H. Edgell, W. Seka, Mark D. Wittman, R. Q. Gram, D. Jacobs-Perkins, R.A. Early, T. Duffy, M. J. Bonino	2006	19
20	Synthesis and antitumor activity of novel paclitaxel–chlorambucil hybrids Bioorganic & Medicinal Chemistry Letters ·Mark D. Wittman, John F. Kadow, Dolatrai M. Vyas, Francis L. Lee, William C. Rose, Byron H. Long, Craig R. Fairchild, Kathy Johnston	2001	18

About Mark D. Wittman

Mark D. Wittman is a scholar working on Nuclear and High Energy Physics, Organic Chemistry, Molecular Biology, Oncology and Radiation, having authored 57 papers that have together received 1.2k indexed citations. Recurring topics across this work include Laser-Plasma Interactions and Diagnostics (17 papers), Synthetic Organic Chemistry Methods (9 papers), Growth Hormone and Insulin-like Growth Factors (8 papers), Metabolism, Diabetes, and Cancer (7 papers), Cancer Treatment and Pharmacology (7 papers), High-pressure geophysics and materials (7 papers), Nuclear Physics and Applications (7 papers) and Fusion materials and technologies (5 papers). The work is most often cited by research in Organic Chemistry (520 citations), Endocrinology, Diabetes and Metabolism (246 citations), Cancer Research (134 citations), Molecular Biology (575 citations) and Oncology (193 citations). Mark D. Wittman has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Dolatrai M. Vyas, Samuel J. Danishefsky, Randall L. Halcomb, James Kallmerten, Joan M. Carboni, Marco M. Gottardis, Ricardo M. Attar, Ann Greer, Jerzy Golik and David B. Frennesson. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Fusion Science & Technology, Tetrahedron Letters, The Journal of Organic Chemistry and Journal of Vacuum Science & Technology A Vacuum Surfaces and Films.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mark D. Wittman

Impact in

Papers in i

In The Last Decade

Mark D. Wittman

Peers

Countries citing papers authored by Mark D. Wittman

Fields of papers citing papers by Mark D. Wittman

All Works

About Mark D. Wittman

Explore authors with similar magnitude of impact

Papers in